Nasdaq GlobeNewswire

Aegex Technologies Announces Strategy at SPE Offshore Europe 2017 to License Intrinsic Safety Designs and Services to Improve Safety in Oil & Gas Operations

Del

Calls on Offshore Equipment Manufacturers to Collaborate to Make All Mobile Devices Intrinsically Safe

ABERDEEN, United Kingdom, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Aegex Technologies, the leader in intrinsically safe mobile devices and Internet of Things (IoT) solutions for hazardous area industrial operations, has announced it will license access to its intrinsic safety designs for mobile devices. It will also provide production and testing services to other technology companies serving the oil & gas industry. This strategy leverages Aegex's proprietary intrinsically safe technology to promote collaboration and further innovation in the offshore equipment industry, enabling greater operational safety and efficiency.

Aegex made the announcement today during the SPE Offshore Europe 2017 exhibition, Europe's largest oil & gas exploration and production technology showcase. The company is demonstrating its Aegex10 Intrinsically Safe Tablet and IoT Platform at Stand #2C120 in the event's Technology Zone.

"In the same spirit that the OGTC [The Oil & Gas Technology Centre] here in Aberdeen is aggregating the strengths of technology companies to create new solutions for the offshore industry, Aegex will license and provide other manufacturers access to our intrinsically safe technology, manufacturing facilities and testing grounds," said Aegex CEO Thomas P. Ventulett. "The goal is to make sure every device used in hazardous area operations is the absolute safest possible."

"Intrinsically safe" (IS) devices, such as Aegex's flagship product, the Aegex10 IS Tablet, are certified under international standards for the most potentially explosive conditions, including Zone 1 areas of oil & gas operations. IS devices are designed to limit a concentration of heat or energy that could ignite combustible environments, or "hazardous areas." This is distinct from "explosion-proof" devices, which do not necessarily prevent an explosion but encapsulate it in a protective housing. The benefit of the Aegex design is that equipment is intrinsically safe "from the inside," rather than relying on heavy and expensive explosion-proof form factors.

Aegex will use its proprietary methodologies to assist companies to make offshore solutions intrinsically safe, such as IoT sensors, wearables, accessories, peripherals and scanners that help increase efficiency and safety across operations, from inventory management to equipment maintenance to personnel health.

The new Aegex services include support from the company's research and development division, AegexLabs, which is comprised of an innovation center, engineering and design studio, and manufacturing facilities in Hungary, plus an 800-acre testing facility in the United States, where it tests hazardous area products under realistic conditions.

"Oil and gas operators are increasingly seeking IoT technologies that can help them work more efficiently and more safely. Aegex wants to offer our expertise to other innovators and collectively develop new technologies that can truly reduce costs, increase productivity and enhance safety in offshore industries," Mr. Ventulett added.

Multiple regional and international standards govern the safety and quality of all equipment used in oil & gas operations. These standards - including directives regulated by ATEX, IECEx, UL and other standards bodies - exist to prevent the accidental ignition of combustible atmospheres by an electronic device.

The Aegex10 tablet is globally certified as intrinsically safe for ATEX/IECEx Zone 1 and UL Class I, II, III Division 1 hazardous areas, where flammable materials are likely to be present during normal operations.

About Aegex Technologies
With world headquarters in Atlanta, Ga., USA, European headquarters in Rotterdam, Netherlands, sales offices in Southampton, UK and Dubai, UAE, and distributors worldwide, Aegex provides intrinsically safe mobile and Internet of Things (IoT) solutions for hazardous locations in oil & gas, chemical, pharmaceutical, public safety and other industries with explosive environments.

Contact Aegex for more details. Watch an Aegex overview video to learn more. LinkedIn Twitter Facebook Google+ Instagram

Leigh Villegas
Marketing & Communications Director
+1 229 220 9660
press@aegex.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aegex Technologies via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer23.1.2018 21:11Pressemelding

DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of cancer death worldwide. To ensure that clinicians stay apace and provide optimal patient care, three leading medical societies-the College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP)-have updated their 2013 evidence-based guideline. Published today in early online release, the "Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors," continues to set standards for the molecular analysis of lung cancers for test results that effectively guide targeted therapy and treatment. Targeted cancer therapies are drugs or other treatments that block the spread of cancer by interfering with specific molec

CashBet Seeks $40 Million for World's Only Complete Crypto-Ready Mobile iGaming Platform23.1.2018 16:31Pressemelding

Gaming and cryptocurrency industry leaders develop blockchain-based iGaming platform improving trust, speed, access, costs, and content availability OAKLAND, Calif., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Leading mobile-first iGaming platform provider CashBet (https://coin.cashbet.com/) today announced it seeks to raise $40 million through an Initial Coin Offering (ICO) to develop the world's first complete crypto-ready mobile iGaming platform. Interactive gaming, which includes real money, social, skill-based, esports and sports betting, hit $91 billion in 2016, led by mobile gaming. Despite strong growth, current iGaming operations continue to face three major issues: trust, speed, and cost. CashBet is the first and only vertically integrated iGaming solution to leverage blockchain technology for transparent operations, increased speed, and lower transaction fees. The CashBet Coin will be available in pre-sale starting January 24, 2018 at 5:00 p.m. GMT, with a 20 percent discount offered.

BrandSafway Announces Acquisition of Venko Groep BV23.1.2018 16:30Pressemelding

Combined customers to benefit from broader range of services and greater depth of expertise KENNESAW, GA, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Brand Industrial Services, known as BrandSafway, has acquired Venko Groep BV, a portfolio company of Mentha Capital, effective January 1, 2018. Moving forward, the company will operate as Venko, A BrandSafway Company and become a part of Brand Energy & Infrastructure Services (Brand) in Europe. "We're excited to announce the closing of the acquisition of Venko," said Dave Witsken, President of Energy and Industrial for BrandSafway. "Venko is a leading offshore coatings maintenance provider for platforms in Europe. By leveraging the highly specialized knowledge and capabilities of Venko, we will be able to provide expanded coatings services to Brand's European customers. At the same time, with our support, Venko will now be able to offer their customers a broader inventory of access equipment and additional industrial services, such as insulation an

Mitratech's TeamConnect Rated Most Widely Used Matter Management System in HBR Consulting's Annual Law Department Survey23.1.2018 15:00Pressemelding

HBR's Annual Survey further validates TeamConnect's market leadership AUSTIN, Texas, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Mitratech, the leading provider of legal, compliance, and risk management software solutions announced that TeamConnect, the market-leading ELM (enterprise legal management) platform, was rated the most widely used matter management system and the second most widely used e-Billing system in the 2017 HBR Consulting (HBR) Law Department Survey. HBR's Law Department Survey released this month rated Mitratech's TeamConnect as the most widely used system for matter management out of the 13 systems included in the survey. All told, Mitratech's ELM solutions accounted for more than a third of the matter management user base. TeamConnect also was rated for the third year in a row as the second most widely used e-Billing system, continuing a years-long trend of customers shifting to Mitratech's integrated ELM platform from other point solutions. Customer satisfaction continues

Data on Novel Humanized Models for Targeted Immunotherapy Development, a CrownBio Conference Talk on January 24th, 201823.1.2018 14:53Pressemelding

SAN DIEGO, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, will unveil data supporting use of its cost-effective, humanized drug target models at the Tumor Models Conference in San Francisco tomorrow, Wednesday, January 24th, 2018. Humanized research tools are crucial to the development of target-specific immunotherapies like pembrolizumab and ipilimumab. To help improve research in this burgeoning field, CrownBio has developed a humanized platform that informs the preclinical pharmacology of targeted immunotherapies, including solutions for PD-1, PD-L1, OX40, and CD3E. Constituent models feature fully functional murine immunity with humanized drug targets that can be used in conjunction with syngeneic tumor cell lines engineered to expr

Music Legend Joey Fatone Will Be Celebrity Grand Marshal Of First Ever 15th Annual World's Shortest St. Patrick's Day Parade In Hot Springs, Arkansas23.1.2018 13:56Pressemelding

HOT SPRINGS NATIONAL PARK, Ark., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Music legend Joey Fatone, who soared to worldwide fame as a member of boy-band *NSYNC, will be celebrity grand marshal of the First Ever 15th Annual World's Shortest St. Patrick's Day Parade in downtown Hot Springs March 17, 2018, reports Hot Springs Convention & Visitors Bureau. He'll round out a quartet of celebrities who will be part of the quirky parade, which annually draws throngs to world-famous Bridge Street, the shortest street in the world in everyday use - 98 feet long. Jon Heder, who became famous as Napoleon Dynamite, will be the parade's official starter. The 2018 parade will begin at 7:30 p.m., an hour later than previous years. The start time was changed to allow Oaklawn racing fans plenty of time to enjoy the live racing including The Rebel Stakes at Oaklawn Park, and still get downtown for the start of the parade. Morris Day and the Time will perform a free concert at the conclusion of the parade. On F

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom